TriReme Medical Inc. Receives FDA Approval for Glider PTCA Catheter

 

May 23, 2012

TriReme Medical Inc. announced on May 23, 2012, approval by the U.S. Food and Drug Administration (FDA) of the Glider PTCA Catheter, indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion. Glider is the only torqueable PTCA balloon catheter. Combined with its state of the art tip technology, Glider is designed to perform, even in the most challenging conditions. It is also available in an ultra-short balloon length of 4 mm designed for focal lesions.

In a related piece of news, William L. Lombardi, M.D. of PeaceHealth St. Joseph Medical Center, Bellingham, Wash. performed the first case using Glider in the United States. "I was able to successfully use Glider to dilate a focal side branch lesion in a complex case and achieve a great outcome without the use of kissing balloons," stated Lombardi. "I am delighted to be the first Glider user in the United States and believe that Glider presents a new and effective way of navigating through complex lesions."

For more information: http://www.trirememedical.com/

 

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.